American Society of Hematology

SHERPA: Blue

People

  1. Kumar
    Kumar
  2. Zelenetz
    Zelenetz
  3. Moskowitz
    Moskowitz
  4. Palomba
    Palomba
  5. Hamlin
    Hamlin
  6. Noy
    Noy
  7. Horwitz
    Horwitz
  8. Caron
    Caron
  9. Falchi
    Falchi
  10. Salles
    Salles

Groups

  1. Center for Hematologic Malignancies (96)
  2. Department of Medicine (96)
  3. Hematologic Malignancies, Division of (96)
  4. Lymphoma (96)
  5. Hematology-Oncology Fellows (75)
  6. Population Sciences Research Program (62)
  7. Survivorship Research (53)
  8. Weinberg Fellows (52)
  9. Sloan Kettering Institute Postdocs (50)
  10. Epidemiology and Biostatistics (44)
Search Within
  1. "Anita Kumar"
Formats
  1. Meeting Abstract (77)
  2. Journal Article (17)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Center for Hematologic Malignancies (96)
  2. Department of Medicine (96)
  3. Hematologic Malignancies, Division of (96)
  4. Lymphoma (96)
  5. Hematology-Oncology Fellows (75)
  6. Population Sciences Research Program (62)

More Groups

People
  1. Anita Kumar (96)
  2. Andrew Zelenetz (79)
  3. Alison Moskowitz (65)
  4. Maria Palomba (64)
  5. Paul Hamlin (63)
  6. Ariela Noy (61)

More People

Years
  1. 2025 (2)
  2. 2024 (21)
  3. 2023 (22)
  4. 2022 (6)
  5. 2021 (7)
  6. 2020 (8)

More Years

Publications
  1. Blood (84)
  2. Blood Advances (11)
  3. Hematology-American Society of Hematology Education Program (1)

Results (96)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas
    Journal Article

    Chong, E. A.; Penuel, E.; Napier, E. B.; Lundberg, R. K.; Budde, L. E.; Shadman, M.; Matasar, M. J.; Bartlett, N. L.; Flinn, I. W.; Bosch, F.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation
    Journal Article

    Kumar, A.; Soumerai, J.; Abramson, J. S.; Barnes, J. A.; Caron, P.; Chhabra, S.; Chabowska, M.; Dogan, A.; Falchi, L.; Grieve, C.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Efficacy and safety outcomes of CAR T-cell therapies in patients with relapsed/refractory B-cell non-Hodgkin lymphoma who received prior treatment with mosunetuzumab
    Meeting Abstract

    Braun, A.; Schuster, S. J.; Nastoupil, L.; Bartlett, N. L.; Shadman, M.; Kumar, A.; Tzachanis, D.; Chihara, D.; Wu, M.; Wei, M. C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Two decade single institution experience highlights rare survivors with relapsed or refractory Burkitt lymphoma
    Meeting Abstract

    Molla, R.; Berman, E.; Caron, P.; Donnelly, G.; Falchi, L.; Hamlin, P. A.; Horwitz, S.; Intlekofer, A. M.; Johnson, W. T.; Jurcic, J. G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Sequential R-CHOP/(R)-ICE and dose-adjusted EPOCH-R are both appropriate frontline treatments for newly diagnosed primary mediastinal B-cell lymphoma: Results of a retrospective analysis
    Meeting Abstract

    Bantilan, K. S.; Luttwak, E.; Moskowitz, C. H.; Matasar, M.; Straus, D. J.; Portlock, C. S.; Moskowitz, A.; Noy, A.; Palomba, M. L.; Horwitz, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Angioimmunoblastic versus non-angioimmunoblastic nodal T-follicular helper cell lymphomas: Single center retrospective analysis on 208 cases
    Meeting Abstract

    Sordi, B.; Eren, O. C.; Ganesan, N.; Iyengar, V.; Stuver, R.; Johnson, W. T.; Moskowitz, A.; Ghione, P.; Galasso, N.; Casper, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A prospective geriatric assessment (GA) study predicting toxicities in older adults (OA) with non-Hodgkin Lymphoma (NHL): Timed up and go test (TUG) time emerges as a functional vital sign
    Meeting Abstract

    Torka, P.; Drill, E.; Ganesan, N.; Truong, R.; Qiu, A.; Amador, W. R.; Oliveros, M.; Boardman, A. P.; Caron, P.; David, K. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab and involved site radiation therapy alone as an alternative to transplant in patients with localized failure following chemotherapy for Hodgkin Lymphoma: A prospective multicenter phase II study
    Meeting Abstract

    Dreyfuss, A.; Ganesan, N.; Alencar, A. J.; Boardman, A. P.; Caron, P.; Chang, T.; Davey, T.; David, K. A.; Dogan, A.; Epstein-Peterson, Z. D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Improved outcomes for primary refractory classical Hodgkin Lymphoma: A retrospective analysis
    Meeting Abstract

    Santarosa, A. M.; Ganesan, N.; Chang, T.; Hannigan, K.; Casper, E.; Shah, G. L.; Boardman, A. P.; Caron, P.; David, K. A.; Dogan, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Real-world outcomes of frontline polatuzumab and impact of frailty in older adults with newly diagnosed diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Iyengar, V.; Chicola, J.; Joseph, A.; Okwali, M.; Truong, R.; Bapodra, N.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; more...
    Blood (2024)

    Fulltext@MSK | Save